Literature DB >> 26248839

Surgery versus SABR for resectable non-small-cell lung cancer.

Masatsugu Hamaji1, Shawn S Groth2, David J Sugarbaker2, Bryan M Burt3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26248839     DOI： 10.1016/S1470-2045(15)00091-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Stage I lung cancer-to operate or to radiate? that is the question.

Authors:  Boris Sepesi; David C Rice; John V Heymach; Ara A Vaporciyan; Stephen G Swisher
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Authors:  Drew Moghanaki; Joe Y Chang
Journal:  Transl Lung Cancer Res       Date:  2016-04

3.  Interpreting survival data from clinical trials of surgery versus stereotactic body radiation therapy in operable Stage I non-small cell lung cancer patients.

Authors:  Pamela Samson; Kathleen Keogan; Traves Crabtree; Graham Colditz; Stephen Broderick; Varun Puri; Bryan Meyers
Journal:  Lung Cancer       Date:  2016-11-09       Impact factor: 5.705

4.  Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience.

Authors:  Michael MacManus; Richard De Abreu Lourenco; Fiona Hegi-Johnson
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.